MRVI News
Archived Headlines
- US IPO Week Ahead: 7 IPOs squeeze in before the Thanksgiving holiday 11/13/20
- Biotech research product provider Maravai LifeSciences sets terms for $1.3 billion IPO 11/13/20
- US IPO Weekly Recap: Big fintechs fall as 11 IPOs squeeze in ahead of the election 10/30/20
- Biotech research product provider Maravai LifeSciences files for a $100 million IPO 10/29/20
These IPOs have outperformed during the biggest sell-off in over a decade
The US IPO Index has plummeted 51% year-to-date, in the IPO market’s sharpest sell-off since at least the 2008 Global Financial Crisis. Of the 397 traditional IPOs in 2021, only 12% are trading above issue. Rampant speculation and near-zero interest rates ...read more
US IPO Week Ahead: The IPO market makes a holiday WISH in a 6 IPO week
Updated Monday, 12/14. Six IPOs and five SPACs are scheduled to raise $2.8 billion in the week ahead as the IPO market starts to slow down before the holidays. Bargain e-commerce platform Wish (WISH) plans to raise $1.1 billion at a $16.4 billion market ...read more
US IPO Weekly Recap: Breast cancer biotech pops 158% in a 6 IPO week
In a scramble to go public ahead of the holiday, six IPOs and 15 SPACs went public this past week led by breast cancer biotech Olema Pharmaceuticals (OLMA), which soared 158% on its first day. New filings continued to pour in, priming the IPO pipeline for an...read more
Genetic products supplier Maravai LifeSciences prices upsized IPO at $27 high end
Maravai LifeSciences, which provides genetic products and testing services for drug development and research, raised $1.6 billion by offering 60 million shares at $27, the high end of the $24 to $27 range. As a supplier of oligonucleotides and products ...read more